Prophylactic non-steroidal anti-inflammatory agents for the prevention of cystoid macular oedema after cataract surgery
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 15 JUN 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Abeysiri P, Wormald R, Bunce C. Prophylactic non-steroidal anti-inflammatory agents for the prevention of cystoid macular oedema after cataract surgery (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 6. Art. No.: CD006683. DOI: 10.1002/14651858.CD006683.pub2.
- Publication Status: Amended to reflect a change in scope (see 'What's new')
- Published Online: 15 JUN 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
The aim of this review is to answer the question: is there sufficient evidence to recommend the prophylactic use of topical NSAIDs in addition to topical steroids postoperatively to reduce the incidence of PMO and associated visual morbidity, compared to current standard practice of topical steroids alone?
This review will be confined to addressing the use of NSAIDs in the prophylaxis of pseudophakic CMO. A separate Cochrane Review on treatment of established CMO has already been published (Sivaprasad 2004) but the effectiveness of NSAIDs in treatment remains uncertain. PMO can lead to permanent structural damage in the central retina, therefore a prevention strategy may be more effective than treatment after the damage has been done.